ask="9.95"
ask_size="100"
average_daily_volume="165590"
bid="4.15"
bid_size="100"
book_value="0.00"
change="-0.08"
change_from_200_day_moving_average="5.92"
change_from_50_day_moving_average="3.88"
change_from_52_week_high="-5.65"
change_From_52_week_low="2.05"
change_in_percent="-0.97%"
close="8.15"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="0.00"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="N/A"
high="8.23"
high_52_weeks="13.80"
last_trade_date="1/5/2017"
last_trade_price="8.15"
last_trade_size="100"
last_trade_time="4:00pm"
low="8.05"
low_52_weeks="6.10"
market_capitalization="755.13B"
moving_average_200_day="2.23"
moving_average_50_day="4.27"
name="Novelion Therapeutics Inc."
notes="N/A"
one_year_target_price="13.50"
open="8.21"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+265.58%"
percent_change_from_50_day_moving_average="+91.07%"
percent_change_from_52_week_high="-40.94%"
percent_change_from_52_week_low="+33.61%"
previous_close="8.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="92654000000"
short_ratio="0.00"
stock_exchange="NMS"
symbol="NVLN"
volume="90979"
weeks_range_52="6.10 - 13.80"
